Non-coding RNAs as a prospect in diagnostics and treatment of cardiovascular diseases
Nekodirajuće RNK kao perspektiva u dijagnostici i lečenju kardiovaskularnih bolesti
Аутори
Rakićević, LjiljanaОстала ауторства
Pavlović, SonjaBegović, Jelena
Novaković, Ivana
Savić Pavićević, Dušanka
Đorđević, Ana
Поглавље у монографији (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Kardiovaskularne bolesti (KVB) su klasa oboljenja koja obuhvataju srce i/ili krvne sudove i nastaju složenim
sadejstvom genetičkih i stečenih faktora. Razvoj molekularne biologije omogućio je nove uvide u fundamentalne
mehanizme koji dovode do KVB, kao i napredak u dijagnostici, prognostici i lečenju. Novi pristupi
u dijagnostici i lečenju KVB podstaknuti su istraživanjima koja se odnose na nekodirajuće RNK - duge nekodirajuće
RNK i kratke nekodirajuće RNK. Ova klasa molekula, ne samo da se povezuje sa različitim mehanizmima
koji dovode do razvoja KVB, nego se prepoznaje njihov potencijal kao biomarkera,
farmakogenetičkih faktora, novih meta lekova i novih alatki u lečenju bolesti. Upotreba nekih od njih u lečenju
ljudi je i odobrena od strane relevantnih agencija. Posebnu pažnju privlače studije koje se odnose na
nekodirajuće RNK poreklom iz ekstracelularnih vezikula, dodatno potvrđujući potencijal nekodirajuće RNK
kao leka budućnosti, ne samo u tretmanu KVB.
Cardiovascular diseases (CVDs) are group of diseases which encompass heart and/or blood vessels and they
originate from complex coaction of genetic and acquired factors. Development of molecular biology has enabled
new insights into fundamental mechanisms which lead to CVDs, as well as progress in diagnostics,
prognosis and treatment. New approaches to diagnostics and treatment of CVDs have been encouraged
by researches which are related to non-coding RNA, long non-coding and short non-coding RNA. Not only
is this group of molecules being associated with different mechanisms which lead to CVDs, but their potential
to be biomarkers, pharmacogenetic factors, new drug targets and new treatment tools is being recognised.
Relevant agencies have approved some of them to be used for human treatments. Studies related to
non-coding RNAs deriving from extracellular vesicles are getting special attention, additionally confirming
non-coding RNAs potential as drug of the future, not limite...d just to CVDs.
Кључне речи:
kardiovaskularne bolesti / nekodirajuće RNK / biomarkeri / cardiovascular diseases / non-coding RNAs / biomarkersИзвор:
Trendovi u molekularnoj Biologiji, 2021, 146-151Издавач:
- Beograd : Institut za molekularnu genetiku i genetičko inženjerstvo
Финансирање / пројекти:
- Министарство науке, технолошког развоја и иновација Републике Србије, институционално финансирање - 200042 (Универзитет у Београду, Институт за молекуларну генетику и генетичко инжењерство) (RS-MESTD-inst-2020-200042)
Колекције
Институција/група
Institut za molekularnu genetiku i genetičko inženjerstvoTY - CHAP AU - Rakićević, Ljiljana PY - 2021 UR - https://imagine.imgge.bg.ac.rs/handle/123456789/1718 AB - Kardiovaskularne bolesti (KVB) su klasa oboljenja koja obuhvataju srce i/ili krvne sudove i nastaju složenim sadejstvom genetičkih i stečenih faktora. Razvoj molekularne biologije omogućio je nove uvide u fundamentalne mehanizme koji dovode do KVB, kao i napredak u dijagnostici, prognostici i lečenju. Novi pristupi u dijagnostici i lečenju KVB podstaknuti su istraživanjima koja se odnose na nekodirajuće RNK - duge nekodirajuće RNK i kratke nekodirajuće RNK. Ova klasa molekula, ne samo da se povezuje sa različitim mehanizmima koji dovode do razvoja KVB, nego se prepoznaje njihov potencijal kao biomarkera, farmakogenetičkih faktora, novih meta lekova i novih alatki u lečenju bolesti. Upotreba nekih od njih u lečenju ljudi je i odobrena od strane relevantnih agencija. Posebnu pažnju privlače studije koje se odnose na nekodirajuće RNK poreklom iz ekstracelularnih vezikula, dodatno potvrđujući potencijal nekodirajuće RNK kao leka budućnosti, ne samo u tretmanu KVB. AB - Cardiovascular diseases (CVDs) are group of diseases which encompass heart and/or blood vessels and they originate from complex coaction of genetic and acquired factors. Development of molecular biology has enabled new insights into fundamental mechanisms which lead to CVDs, as well as progress in diagnostics, prognosis and treatment. New approaches to diagnostics and treatment of CVDs have been encouraged by researches which are related to non-coding RNA, long non-coding and short non-coding RNA. Not only is this group of molecules being associated with different mechanisms which lead to CVDs, but their potential to be biomarkers, pharmacogenetic factors, new drug targets and new treatment tools is being recognised. Relevant agencies have approved some of them to be used for human treatments. Studies related to non-coding RNAs deriving from extracellular vesicles are getting special attention, additionally confirming non-coding RNAs potential as drug of the future, not limited just to CVDs. PB - Beograd : Institut za molekularnu genetiku i genetičko inženjerstvo T2 - Trendovi u molekularnoj Biologiji T1 - Non-coding RNAs as a prospect in diagnostics and treatment of cardiovascular diseases T1 - Nekodirajuće RNK kao perspektiva u dijagnostici i lečenju kardiovaskularnih bolesti EP - 151 SP - 146 UR - https://hdl.handle.net/21.15107/rcub_imagine_1718 ER -
@inbook{ author = "Rakićević, Ljiljana", year = "2021", abstract = "Kardiovaskularne bolesti (KVB) su klasa oboljenja koja obuhvataju srce i/ili krvne sudove i nastaju složenim sadejstvom genetičkih i stečenih faktora. Razvoj molekularne biologije omogućio je nove uvide u fundamentalne mehanizme koji dovode do KVB, kao i napredak u dijagnostici, prognostici i lečenju. Novi pristupi u dijagnostici i lečenju KVB podstaknuti su istraživanjima koja se odnose na nekodirajuće RNK - duge nekodirajuće RNK i kratke nekodirajuće RNK. Ova klasa molekula, ne samo da se povezuje sa različitim mehanizmima koji dovode do razvoja KVB, nego se prepoznaje njihov potencijal kao biomarkera, farmakogenetičkih faktora, novih meta lekova i novih alatki u lečenju bolesti. Upotreba nekih od njih u lečenju ljudi je i odobrena od strane relevantnih agencija. Posebnu pažnju privlače studije koje se odnose na nekodirajuće RNK poreklom iz ekstracelularnih vezikula, dodatno potvrđujući potencijal nekodirajuće RNK kao leka budućnosti, ne samo u tretmanu KVB., Cardiovascular diseases (CVDs) are group of diseases which encompass heart and/or blood vessels and they originate from complex coaction of genetic and acquired factors. Development of molecular biology has enabled new insights into fundamental mechanisms which lead to CVDs, as well as progress in diagnostics, prognosis and treatment. New approaches to diagnostics and treatment of CVDs have been encouraged by researches which are related to non-coding RNA, long non-coding and short non-coding RNA. Not only is this group of molecules being associated with different mechanisms which lead to CVDs, but their potential to be biomarkers, pharmacogenetic factors, new drug targets and new treatment tools is being recognised. Relevant agencies have approved some of them to be used for human treatments. Studies related to non-coding RNAs deriving from extracellular vesicles are getting special attention, additionally confirming non-coding RNAs potential as drug of the future, not limited just to CVDs.", publisher = "Beograd : Institut za molekularnu genetiku i genetičko inženjerstvo", journal = "Trendovi u molekularnoj Biologiji", booktitle = "Non-coding RNAs as a prospect in diagnostics and treatment of cardiovascular diseases, Nekodirajuće RNK kao perspektiva u dijagnostici i lečenju kardiovaskularnih bolesti", pages = "151-146", url = "https://hdl.handle.net/21.15107/rcub_imagine_1718" }
Rakićević, L.. (2021). Non-coding RNAs as a prospect in diagnostics and treatment of cardiovascular diseases. in Trendovi u molekularnoj Biologiji Beograd : Institut za molekularnu genetiku i genetičko inženjerstvo., 146-151. https://hdl.handle.net/21.15107/rcub_imagine_1718
Rakićević L. Non-coding RNAs as a prospect in diagnostics and treatment of cardiovascular diseases. in Trendovi u molekularnoj Biologiji. 2021;:146-151. https://hdl.handle.net/21.15107/rcub_imagine_1718 .
Rakićević, Ljiljana, "Non-coding RNAs as a prospect in diagnostics and treatment of cardiovascular diseases" in Trendovi u molekularnoj Biologiji (2021):146-151, https://hdl.handle.net/21.15107/rcub_imagine_1718 .